The importance of determining human placental lactogen in the third trimester of pregnancy
Human placental lactogen (HPL) is a hormone produced by the placenta with a role in the regulation of fetoplacental growth. In this paper, the results of HPL determination in the third trimester of pregnancy are presented with the aim of testing the sensitivity of this biochemical marker for detecti...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Medical Biochemists of Serbia, Belgrade
2009-01-01
|
Series: | Journal of Medical Biochemistry |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2009/1452-82580902097D.pdf |
id |
doaj-36ce3fe00ccb4bb6a73da5bcecab1494 |
---|---|
record_format |
Article |
spelling |
doaj-36ce3fe00ccb4bb6a73da5bcecab14942020-11-25T02:38:07ZengSociety of Medical Biochemists of Serbia, BelgradeJournal of Medical Biochemistry1452-82581452-82662009-01-01282971001452-82580902097DThe importance of determining human placental lactogen in the third trimester of pregnancyDurković Jasmina0Mandić Bojana1Department of Genetics, Town Hospital, SuboticaMega Lab, Biochemical Laboratory, SuboticaHuman placental lactogen (HPL) is a hormone produced by the placenta with a role in the regulation of fetoplacental growth. In this paper, the results of HPL determination in the third trimester of pregnancy are presented with the aim of testing the sensitivity of this biochemical marker for detecting placental dysfunction, fetal vitality and risk of bad outcome. The tests were performed on 370 women with high-risk pregnancy, between the 20th and 36th week of pregnancy. HPL was determined by an ELISA method using Bioserv Diagnostics tests and the results were read by a STAT-FAX 303+ reader. When compared to normal pregnancy, a significant decrease in the level of HPL biomarker was identified in preeclampsia (p<0.01), whereas in diabetes the serum level of HPL was significantly higher (p<0.01). A significant positive correlation between the level of HPL during pregnancy and the weight of a newborn child, its head circumference and Apgar score was obtained. The results of the research indicate that the maternal concentration of the HPL biomarker is directly connected to the vitality of placental tissue, so that HPL in the third trimester of pregnancy can be used as an indicator of placental insufficiency and fetal vitality.https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2009/1452-82580902097D.pdfhuman placental lactogenplacental insufficiency |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Durković Jasmina Mandić Bojana |
spellingShingle |
Durković Jasmina Mandić Bojana The importance of determining human placental lactogen in the third trimester of pregnancy Journal of Medical Biochemistry human placental lactogen placental insufficiency |
author_facet |
Durković Jasmina Mandić Bojana |
author_sort |
Durković Jasmina |
title |
The importance of determining human placental lactogen in the third trimester of pregnancy |
title_short |
The importance of determining human placental lactogen in the third trimester of pregnancy |
title_full |
The importance of determining human placental lactogen in the third trimester of pregnancy |
title_fullStr |
The importance of determining human placental lactogen in the third trimester of pregnancy |
title_full_unstemmed |
The importance of determining human placental lactogen in the third trimester of pregnancy |
title_sort |
importance of determining human placental lactogen in the third trimester of pregnancy |
publisher |
Society of Medical Biochemists of Serbia, Belgrade |
series |
Journal of Medical Biochemistry |
issn |
1452-8258 1452-8266 |
publishDate |
2009-01-01 |
description |
Human placental lactogen (HPL) is a hormone produced by the placenta with a role in the regulation of fetoplacental growth. In this paper, the results of HPL determination in the third trimester of pregnancy are presented with the aim of testing the sensitivity of this biochemical marker for detecting placental dysfunction, fetal vitality and risk of bad outcome. The tests were performed on 370 women with high-risk pregnancy, between the 20th and 36th week of pregnancy. HPL was determined by an ELISA method using Bioserv Diagnostics tests and the results were read by a STAT-FAX 303+ reader. When compared to normal pregnancy, a significant decrease in the level of HPL biomarker was identified in preeclampsia (p<0.01), whereas in diabetes the serum level of HPL was significantly higher (p<0.01). A significant positive correlation between the level of HPL during pregnancy and the weight of a newborn child, its head circumference and Apgar score was obtained. The results of the research indicate that the maternal concentration of the HPL biomarker is directly connected to the vitality of placental tissue, so that HPL in the third trimester of pregnancy can be used as an indicator of placental insufficiency and fetal vitality. |
topic |
human placental lactogen placental insufficiency |
url |
https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2009/1452-82580902097D.pdf |
work_keys_str_mv |
AT durkovicjasmina theimportanceofdetermininghumanplacentallactogeninthethirdtrimesterofpregnancy AT mandicbojana theimportanceofdetermininghumanplacentallactogeninthethirdtrimesterofpregnancy AT durkovicjasmina importanceofdetermininghumanplacentallactogeninthethirdtrimesterofpregnancy AT mandicbojana importanceofdetermininghumanplacentallactogeninthethirdtrimesterofpregnancy |
_version_ |
1724792740206608384 |